Global and Japan Liposome Drug Delivery Market Insights, Forecast to 2027

Global and Japan Liposome Drug Delivery Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2016-2027
2.1.2 Global Liposome Drug Delivery Sales 2016-2027
2.2 Global Liposome Drug Delivery, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Liposome Drug Delivery Historical Market Size by Region (2016-2021)
2.3.1 Global Liposome Drug Delivery Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Liposome Drug Delivery Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Liposome Drug Delivery Sales Forecast by Region (2022-2027)
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2022-2027)
3 Global Liposome Drug Delivery Competitor Landscape by Players
3.1 Global Top Liposome Drug Delivery Manufacturers by Sales
3.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2016-2021)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Liposome Drug Delivery Manufacturers by Revenue
3.2.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
3.2.2 Global Liposome Drug Delivery Revenue by Manufacturers (2016-2021)
3.2.3 Global Liposome Drug Delivery Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Liposome Drug Delivery Revenue in 2020
3.2.6 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Liposome Drug Delivery Price by Manufacturers
3.4 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liposome Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Liposome Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Liposome Drug Delivery Market Size by Type (2016-2021)
4.1.1 Global Liposome Drug Delivery Sales by Type (2016-2021)
4.1.2 Global Liposome Drug Delivery Revenue by Type (2016-2021)
4.1.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Liposome Drug Delivery Market Size Forecast by Type (2022-2027)
4.2.1 Global Liposome Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Liposome Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Liposome Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Liposome Drug Delivery Market Size by Application (2016-2021)
5.1.1 Global Liposome Drug Delivery Sales by Application (2016-2021)
5.1.2 Global Liposome Drug Delivery Revenue by Application (2016-2021)
5.1.3 Liposome Drug Delivery Price by Application (2016-2021)
5.2 Liposome Drug Delivery Market Size Forecast by Application (2022-2027)
5.2.1 Global Liposome Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Liposome Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Liposome Drug Delivery Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Liposome Drug Delivery Market Size YoY Growth 2016-2027
6.1.1 Japan Liposome Drug Delivery Sales YoY Growth 2016-2027
6.1.2 Japan Liposome Drug Delivery Revenue YoY Growth 2016-2027
6.1.3 Japan Liposome Drug Delivery Market Share in Global Market 2016-2027
6.2 Japan Liposome Drug Delivery Market Size by Players (International and Local Players)
6.2.1 Japan Top Liposome Drug Delivery Players by Sales (2016-2021)
6.2.2 Japan Top Liposome Drug Delivery Players by Revenue (2016-2021)
6.3 Japan Liposome Drug Delivery Historic Market Review by Type (2016-2021)
6.3.1 Japan Liposome Drug Delivery Sales Market Share by Type (2016-2021)
6.3.2 Japan Liposome Drug Delivery Revenue Market Share by Type (2016-2021)
6.3.3 Japan Liposome Drug Delivery Price by Type (2016-2021)
6.4 Japan Liposome Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Liposome Drug Delivery Sales Forecast by Type (2022-2027)
6.4.2 Japan Liposome Drug Delivery Revenue Forecast by Type (2022-2027)
6.4.3 Japan Liposome Drug Delivery Price Forecast by Type (2022-2027)
6.5 Japan Liposome Drug Delivery Historic Market Review by Application (2016-2021)
6.5.1 Japan Liposome Drug Delivery Sales Market Share by Application (2016-2021)
6.5.2 Japan Liposome Drug Delivery Revenue Market Share by Application (2016-2021)
6.5.3 Japan Liposome Drug Delivery Price by Application (2016-2021)
6.6 Japan Liposome Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Liposome Drug Delivery Sales Forecast by Application (2022-2027)
6.6.2 Japan Liposome Drug Delivery Revenue Forecast by Application (2022-2027)
6.6.3 Japan Liposome Drug Delivery Price Forecast by Application (2022-2027)
7 North America
7.1 North America Liposome Drug Delivery Market Size YoY Growth 2016-2027
7.2 North America Liposome Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposome Drug Delivery Sales by Country (2016-2021)
7.2.2 North America Liposome Drug Delivery Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Liposome Drug Delivery Market Size YoY Growth 2016-2027
8.2 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Region
8.2.1 Asia Pacific Liposome Drug Delivery Sales by Region (2016-2021)
8.2.2 Asia Pacific Liposome Drug Delivery Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Liposome Drug Delivery Market Size YoY Growth 2016-2027
9.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposome Drug Delivery Sales by Country (2016-2021)
9.2.2 Europe Liposome Drug Delivery Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2016-2027
10.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposome Drug Delivery Sales by Country (2016-2021)
10.2.2 Latin America Liposome Drug Delivery Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Liposome Drug Delivery Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2021)
11.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Description and Business Overview
12.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Liposome Drug Delivery Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Pacira
12.2.1 Pacira Corporation Information
12.2.2 Pacira Description and Business Overview
12.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pacira Liposome Drug Delivery Products Offered
12.2.5 Pacira Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Description and Business Overview
12.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Liposome Drug Delivery Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Liposome Drug Delivery Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Description and Business Overview
12.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Liposome Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau
12.6.1 Sigma-Tau Corporation Information
12.6.2 Sigma-Tau Description and Business Overview
12.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sigma-Tau Liposome Drug Delivery Products Offered
12.6.5 Sigma-Tau Recent Development
12.7 Ipsen (Onivyde)
12.7.1 Ipsen (Onivyde) Corporation Information
12.7.2 Ipsen (Onivyde) Description and Business Overview
12.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
12.7.5 Ipsen (Onivyde) Recent Development
12.8 CSPC
12.8.1 CSPC Corporation Information
12.8.2 CSPC Description and Business Overview
12.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CSPC Liposome Drug Delivery Products Offered
12.8.5 CSPC Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Description and Business Overview
12.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Pharmaceutical Liposome Drug Delivery Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Liposome Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Gilead Sciences
12.11.1 Gilead Sciences Corporation Information
12.11.2 Gilead Sciences Description and Business Overview
12.11.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Gilead Sciences Liposome Drug Delivery Products Offered
12.11.5 Gilead Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Liposome Drug Delivery Industry Trends
13.2 Liposome Drug Delivery Market Drivers
13.3 Liposome Drug Delivery Market Challenges
13.4 Liposome Drug Delivery Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liposome Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposome Drug Delivery Market Size Growth Rate by Application (2021-2027) & (K Vial)
Table 7. Global Liposome Drug Delivery Market Size by Region (K Vial) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Liposome Drug Delivery Sales by Regions (2016-2021) & (K Vial)
Table 9. Global Liposome Drug Delivery Sales Market Share by Regions (2016-2021)
Table 10. Global Liposome Drug Delivery Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Liposome Drug Delivery Sales Forecast by Region (2022-2027) & (K Vial)
Table 12. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Liposome Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Liposome Drug Delivery Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Liposome Drug Delivery Sales by Manufacturers (2016-2021) (K Vial)
Table 16. Global Liposome Drug Delivery Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Liposome Drug Delivery Manufacturers by Revenue (US$ Million) in 2020
Table 18. Liposome Drug Delivery Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Liposome Drug Delivery Revenue Share by Manufacturers (2016-2021)
Table 20. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Drug Delivery as of 2020)
Table 22. Key Manufacturers Liposome Drug Delivery Price (2016-2021) (USD/Vial)
Table 23. Liposome Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liposome Drug Delivery Product Type
Table 25. Date of International Manufacturers Enter into Liposome Drug Delivery Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposome Drug Delivery Sales by Type (2016-2021) (K Vial)
Table 28. Global Liposome Drug Delivery Sales Share by Type (2016-2021)
Table 29. Global Liposome Drug Delivery Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Liposome Drug Delivery Revenue Share by Type (2016-2021)
Table 31. Liposome Drug Delivery Average Selling Price (ASP) by Type (2016-2021) & (USD/Vial)
Table 32. Global Liposome Drug Delivery Sales Forecast by Type (2022-2027) & (K Vial)
Table 33. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Liposome Drug Delivery Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Liposome Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Vial)
Table 37. Global Liposome Drug Delivery Sales by Application (2016-2021) (K Vial)
Table 38. Global Liposome Drug Delivery Sales Share by Application (2016-2021)
Table 39. Global Liposome Drug Delivery Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Liposome Drug Delivery Revenue Share by Application (2016-2021)
Table 41. Liposome Drug Delivery Average Selling Price (ASP) by Application (2016-2021) & (USD/Vial)
Table 42. Global Liposome Drug Delivery Sales Forecast by Application (2022-2027) & (K Vial)
Table 43. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Liposome Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Liposome Drug Delivery Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Vial)
Table 47. Japan Liposome Drug Delivery Sales (K Vial) of Key Companies (2016-2021)
Table 48. Japan Liposome Drug Delivery Sales Share by Company (2016-2021)
Table 49. Japan Liposome Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Liposome Drug Delivery Revenue Share by Company (2016-2021)
Table 51. Japan Liposome Drug Delivery Sales (K Vial) by Type (2016-2021)
Table 52. Japan Liposome Drug Delivery Sales Share by Type (2016-2021)
Table 53. Japan Liposome Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Liposome Drug Delivery Price (USD/Vial) by Type (2016-2021)
Table 55. Japan Liposome Drug Delivery Sales (K Vial) by Type (2022-2027)
Table 56. Japan Liposome Drug Delivery Sales Share by Type (2022-2027)
Table 57. Japan Liposome Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Liposome Drug Delivery Revenue Share by Type (2022-2027)
Table 59. Japan Liposome Drug Delivery Price (USD/Vial) by Type (2022-2027)
Table 60. Japan Liposome Drug Delivery Sales (K Vial) by Application (2016-2021)
Table 61. Japan Liposome Drug Delivery Sales Share by Application (2016-2021)
Table 62. Japan Liposome Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Liposome Drug Delivery Price (USD/Vial) by Application (2016-2021)
Table 64. Japan Liposome Drug Delivery Sales (K Vial) by Application (2022-2027)
Table 65. Japan Liposome Drug Delivery Sales Share by Application (2022-2027)
Table 66. Japan Liposome Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Liposome Drug Delivery Revenue Share by Application (2022-2027)
Table 68. Japan Liposome Drug Delivery Price (USD/Vial) by Application (2022-2027)
Table 69. North America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 70. North America Liposome Drug Delivery Sales Market Share by Country (2016-2021)
Table 71. North America Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Liposome Drug Delivery Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 74. Asia Pacific Liposome Drug Delivery Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Liposome Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Liposome Drug Delivery Revenue Market Share by Region (2016-2021)
Table 77. Europe Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 78. Europe Liposome Drug Delivery Sales Market Share by Country (2016-2021)
Table 79. Europe Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Liposome Drug Delivery Revenue Market Share by Country (2016-2021)
Table 81. Latin America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 82. Latin America Liposome Drug Delivery Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Liposome Drug Delivery Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 86. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2016-2021)
Table 89. Gilead Sciences Corporation Information
Table 90. Gilead Sciences Description and Business Overview
Table 91. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 92. Gilead Sciences Liposome Drug Delivery Product
Table 93. Gilead Sciences Recent Development
Table 94. Pacira Corporation Information
Table 95. Pacira Description and Business Overview
Table 96. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 97. Pacira Product
Table 98. Pacira Recent Development
Table 99. Sun Pharmaceutical Corporation Information
Table 100. Sun Pharmaceutical Description and Business Overview
Table 101. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 102. Sun Pharmaceutical Product
Table 103. Sun Pharmaceutical Recent Development
Table 104. Johnson & Johnson Corporation Information
Table 105. Johnson & Johnson Description and Business Overview
Table 106. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Recent Development
Table 109. Luye Pharma Corporation Information
Table 110. Luye Pharma Description and Business Overview
Table 111. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 112. Luye Pharma Product
Table 113. Luye Pharma Recent Development
Table 114. Sigma-Tau Corporation Information
Table 115. Sigma-Tau Description and Business Overview
Table 116. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 117. Sigma-Tau Product
Table 118. Sigma-Tau Recent Development
Table 119. Ipsen (Onivyde) Corporation Information
Table 120. Ipsen (Onivyde) Description and Business Overview
Table 121. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 122. Ipsen (Onivyde) Product
Table 123. Ipsen (Onivyde) Recent Development
Table 124. CSPC Corporation Information
Table 125. CSPC Description and Business Overview
Table 126. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 127. CSPC Product
Table 128. CSPC Recent Development
Table 129. Teva Pharmaceutical Corporation Information
Table 130. Teva Pharmaceutical Description and Business Overview
Table 131. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 132. Teva Pharmaceutical Product
Table 133. Teva Pharmaceutical Recent Development
Table 134. Novartis Corporation Information
Table 135. Novartis Description and Business Overview
Table 136. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 137. Novartis Product
Table 138. Novartis Recent Development
Table 139. Fudan-Zhangjiang Corporation Information
Table 140. Fudan-Zhangjiang Description and Business Overview
Table 141. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 142. Fudan-Zhangjiang Product
Table 143. Fudan-Zhangjiang Recent Development
Table 144. Liposome Drug Delivery Market Trends
Table 145. Liposome Drug Delivery Market Drivers
Table 146. Liposome Drug Delivery Market Challenges
Table 147. Liposome Drug Delivery Market Restraints
Table 148. Liposome Drug Delivery Customers List
Table 149. Liposome Drug Delivery Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Sales Market Share by Type in 2020 & 2027
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposome Drug Delivery Sales Market Share by Application in 2020 & 2027
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Others
Figure 11. Liposome Drug Delivery Report Years Considered
Figure 12. Global Liposome Drug Delivery Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Liposome Drug Delivery Market Size 2016-2027 (US$ Million)
Figure 14. Global Liposome Drug Delivery Sales 2016-2027 (K Vial)
Figure 15. Global Liposome Drug Delivery Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Liposome Drug Delivery Sales Market Share by Region (2016-2021)
Figure 17. Global Liposome Drug Delivery Sales Market Share by Region in 2020
Figure 18. Global Liposome Drug Delivery Revenue Market Share by Region (2016-2021)
Figure 19. Global Liposome Drug Delivery Revenue Market Share by Region in 2020
Figure 20. Global Liposome Drug Delivery Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Liposome Drug Delivery Revenue in 2020
Figure 22. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Figure 24. Global Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 25. Global Liposome Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Type in 2020
Figure 27. Global Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Figure 28. Global Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 29. Global Liposome Drug Delivery Revenue Market Share by Application (2016-2021)
Figure 30. Global Liposome Drug Delivery Revenue Market Share by Application in 2020
Figure 31. Japan Liposome Drug Delivery Sales Growth Rate 2016-2027 (K Vial)
Figure 32. Japan Liposome Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Liposome Drug Delivery Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Liposome Drug Delivery Players Market Share by Revenue in Liposome Drug Delivery in 2020
Figure 35. Japan Liposome Drug Delivery Revenue Share by Type (2016-2021)
Figure 36. Japan Liposome Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Liposome Drug Delivery Revenue Share by Application (2016-2021)
Figure 38. Japan Liposome Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Liposome Drug Delivery Sales Growth Rate 2016-2021 (K Vial)
Figure 40. North America Liposome Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Liposome Drug Delivery Sales Market Share by Country in 2020
Figure 42. North America Liposome Drug Delivery Revenue Market Share by Country in 2020
Figure 43. U.S. Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 44. U.S. Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 46. Canada Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Liposome Drug Delivery Sales Growth Rate 2016-2021 (K Vial)
Figure 48. Europe Liposome Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Liposome Drug Delivery Sales Market Share by Country in 2020
Figure 50. Europe Liposome Drug Delivery Revenue Market Share by Country in 2020
Figure 51. Germany Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 52. Germany Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 54. France Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 56. U.K. Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 58. Italy Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 60. Russia Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Liposome Drug Delivery Sales Growth Rate 2016-2021 (K Vial)
Figure 62. Asia Pacific Liposome Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Liposome Drug Delivery Sales Market Share by Region in 2020
Figure 64. Asia Pacific Liposome Drug Delivery Revenue Market Share by Region in 2020
Figure 65. China Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 66. China Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 68. Japan Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 70. South Korea Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 72. India Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 74. Australia Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 76. Taiwan Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 78. Indonesia Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 80. Thailand Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 82. Malaysia Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 84. Philippines Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Liposome Drug Delivery Sales Growth Rate (2016-2021) (K Vial)
Figure 86. Vietnam Liposome Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Liposome Drug Delivery Sales Growth Rate 2016-2021 (K Vial)
Figure 8

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs